Copyright © 2019. Inderes Oy. All rights reserved.
Search
User account

Hei!

Luo ilmainen tili jotta voit seurata yrityksiä, osallistua foorumin keskusteluun sekä kommentoida meidän sisältöä. Valitse sinulle sopivin tili.

Oliko sinulla jo tili?

Log in
Herantis Pharma
1409 investors follow this company
The company is not covered. See all listed companies from here.
BUY 9.75 LOWEST 9.40 VOLUME 5 370
SELL 10.10 HIGHEST 10.40 VALUE 0,054 Milj. EUR

Would you like to see our recommendations and target prices?

You already have an Inderes account? Log in from here.

Latest insider trading

Type: stock_exchange_release
10.12.
2019

Herantis Pharma Plc has submitted a listing application to Nasdaq Stockholm AB for the listing of the offer shares

Herantis Pharma Plc
Company release 10 December 2019 at 4:00 PM EET

THE INFORMATION CONTAINED IN THIS RELEASE IS NOT FOR PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN OR INTO AUSTRALIA, CANADA, HONG KONG, JAPAN, SINGAPORE, SOUTH AFRICA OR THE UNITED STATES OR IN ANY OTHER JURISDICTION IN WHICH PUBLICATION OR DISTRIBUTION WOULD BE UNLAWFUL.

Type: stock_exchange_release
9.12.
2019

Offer shares of Herantis Pharma Plc registered with the Trade Register

Herantis Pharma Plc
Company release 9 December 2019 at 3:00 pm EET

THE INFORMATION CONTAINED IN THIS RELEASE IS NOT FOR PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN OR INTO AUSTRALIA, CANADA, HONG KONG, JAPAN, SINGAPORE, SOUTH AFRICA OR THE UNITED STATES OR IN ANY OTHER JURISDICTION IN WHICH PUBLICATION OR DISTRIBUTION WOULD BE UNLAWFUL.

Type: stock_exchange_release
2.12.
2019

Herantis Pharma Plc's directed share issue is oversubscribed multiple times and completed as planned

Herantis Pharma Plc
Company release 2 December 2019 at 8:00 pm

THE INFORMATION CONTAINED IN THIS RELEASE IS NOT FOR PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN OR INTO AUSTRALIA, CANADA, HONG KONG, JAPAN, SINGAPORE, SOUTH AFRICA OR THE UNITED STATES OR IN ANY OTHER JURISDICTION IN WHICH PUBLICATION OR DISTRIBUTION WOULD BE UNLAWFUL.

Type: stock_exchange_release
11.11.
2019

Herantis Pharma Plc commences a directed share issue, contemplates secondary listing on Nasdaq First North Growth Market Sweden and expands its management team

Herantis Pharma Plc
Inside information 11 November 2019 at 09:00 EET

THE INFORMATION CONTAINED IN THIS RELEASE IS NOT FOR PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN OR INTO AUSTRALIA, CANADA, HONG KONG, JAPAN, SINGAPORE, SOUTH AFRICA OR THE UNITED STATES OR IN ANY OTHER JURISDICTION IN WHICH PUBLICATION OR DISTRIBUTION WOULD BE UNLAWFUL.

Type: stock_exchange_release
4.11.
2019

Herantis Pharma publishes newsletter for September-October

Herantis Pharma Plc
Press release 4 November 2019 at 9:00 am

Herantis Pharma plc (“Herantis”) has published its newsletter for September-October 2019. The newsletter is also attached to this press release.

Type: stock_exchange_release
26.9.
2019

Herantis Pharma Plc Provides Update on Timeline for Ongoing Phase 1-2 CDNF Trial

Herantis Pharma Plc
Company release 26 September 2019 at 9:00 AM

Type: stock_exchange_release
2.9.
2019

Herantis Pharma publishes newsletter for July-August

Herantis Pharma Plc
Press release 2 September 2019 at 9:00 am

Herantis Pharma plc (“Herantis”) has published its newsletter for July-August 2019. The newsletter is also attached to this press release.

Type: stock_exchange_release
28.8.
2019

Herantis Pharma Plc

Company release August 28, 2019 at 9:00am

Herantis Pharma Plc announces half year financial report January 1 - June 30, 2019 (unaudited)

  • Randomized clinical studies in Parkinson’s and lymphedema proceed as planned
  • Pipeline expansion with next generation xCDNF

Highlights January-June 2019

Type: stock_exchange_release
1.7.
2019

Herantis Pharma publishes newsletter for May-June

Herantis Pharma Plc
Press release 1 July 2019 at 9:00 am

Herantis Pharma plc (“Herantis”) has published its newsletter for May-June 2019. The newsletter is also attached to this press release.

Type: stock_exchange_release
31.5.
2019

Herantis Pharma Oyj: Manager’s Transactions - Inveni Life Sciences Fund I Ky

Herantis Pharma Plc
Company release 31 May 2019 at 1:00 pm

Herantis Pharma Oyj - Managers' Transactions

____________________________________________

Person subject to the notification requirement

Name: Inveni Life Sciences Fund I Ky

Position: Closely associated person

(X) Legal person

(1):Person Discharging Managerial Responsibilities In Issuer

Name: Prihti, Aki

Position: Member of the Board

Herantis Pharma

English translation unavailable for Herantis Pharma.
Herantis Pharma